0,899  0,006  Apoptosis agonist
0,867  0,002  Estrogen receptor alpha antagonist
0,855  0,002  NOS3 expression enhancer
0,856  0,004  Antiosteoporotic
0,829  0,003  Estrogen antagonist
0,822  0,004  Antioxidant
0,821  0,004  Bone diseases treatment
0,806  0,004  Free radical scavenger
0,816  0,016  Alpha-glucosidase inhibitor
0,789  0,002  Cystathionine beta-synthase inhibitor
0,770  0,012  Antineoplastic (breast cancer)
0,738  0,003  Estrogen receptor beta antagonist
0,751  0,018  Caspase 9 stimulant
0,732  0,003  Topoisomerase II inhibitor
0,730  0,002  Estrogen agonist
0,703  0,009  Prostate cancer treatment
0,692  0,005  Amyloid beta aggregation inhibitor
0,690  0,012  Alzheimer's disease treatment
0,681  0,020  Antineoplastic (lung cancer)
0,667  0,007  Nitric oxide antagonist
0,657  0,005  Antimutagenic
0,653  0,004  Skin whitener
0,676  0,035  Antiinflammatory
0,641  0,007  UGT1A6 substrate
0,628  0,009  Caspase 3 stimulant
0,626  0,010  UGT1A9 substrate
0,616  0,002  Estrogen receptor beta agonist
0,629  0,028  Transcription factor NF kappa B inhibitor
0,595  0,006  Vasodilator
0,589  0,011  NOS2 expression inhibitor
0,586  0,020  Antiparkinsonian
0,576  0,014  Chemopreventive
0,563  0,004  Lipid peroxidase inhibitor
0,560  0,003  Postmenopausal disorders treatment
0,584  0,030  Cyclophilin D inhibitor
0,584  0,030  Antidiabetic
0,554  0,004  Topoisomerase I inhibitor
0,554  0,014  AR expression inhibitor
0,554  0,025  Aldehyde oxidase inhibitor
0,540  0,017  Cardioprotectant
0,527  0,009  Antihypertriglyceridemic
0,516  0,005  Amylase inhibitor
0,517  0,006  UGT1A3 substrate
0,529  0,026  Immunosuppressant
0,507  0,007  Genotoxic
0,530  0,035  Antileukemic
0,527  0,033  Antibacterial
0,503  0,012  UDP-glucuronosyltransferase substrate
0,495  0,004  UGT2B15 substrate
0,520  0,033  Antineoplastic (colorectal cancer)
0,507  0,021  CTGF expression inhibitor
0,491  0,009  P-glycoprotein inhibitor
0,482  0,005  Acetylcholinesterase inhibitor
0,494  0,025  CYP2C19 inhibitor
0,488  0,022  Apoptosis antagonist
0,486  0,022  NOS3 expression inhibitor
0,501  0,040  15-Lipoxygenase inhibitor
0,499  0,047  TNF expression inhibitor
0,463  0,012  UGT1A1 substrate
0,475  0,025  Antineoplastic (cervical cancer)
0,475  0,027  CYP1A2 substrate
0,479  0,036  Antineoplastic (colon cancer)
0,461  0,025  Cytostatic
0,454  0,020  Hypoglycemic
0,444  0,010  Monophenol monooxygenase inhibitor
0,471  0,040  Histamine release inhibitor
0,455  0,027  Chemoprotective
0,453  0,027  Antineoplastic (glioma)
0,427  0,004  SULT1A3 substrate
0,429  0,008  Cholinergic
0,449  0,034  Antihypercholesterolemic
0,444  0,033  Antifungal
0,439  0,030  Antineoplastic (brain cancer)
0,429  0,023  DNA damaging
0,425  0,025  UGT2B4 substrate
0,432  0,032  Antimycobacterial
0,437  0,043  Angiogenesis inhibitor
0,419  0,033  Lipoxygenase inhibitor
0,386  0,004  Histone deacetylase class III inhibitor
0,381  0,004  Histone deacetylase SIRT1 inhibitor
0,391  0,015  Contraceptive
0,384  0,015  Hepatoprotectant
0,399  0,030  Hypoxia-inducible factor 1 alpha inhibitor
0,371  0,003  Estrogen receptor alpha agonist
0,403  0,039  ICAM1 expression inhibitor
0,392  0,035  Antituberculosic
0,363  0,008  Sulfotransferase substrate
0,358  0,015  Melanin inhibitor
0,375  0,033  Mutagenic
0,373  0,032  Antineoplastic (glioblastoma multiforme)
0,371  0,034  Proliferative diseases treatment
0,337  0,005  Dopamine agonist
0,353  0,022  GST M1-1 substrate
0,335  0,009  Protein-tyrosine phosphatase 1B inhibitor
0,371  0,051  CYP2D6 substrate
0,383  0,067  CYP3A4 substrate
0,320  0,006  Topoisomerase II alpha inhibitor
0,352  0,038  Antiamyloidogenic
0,320  0,007  Antihemorrhagic
0,323  0,015  Protein-tyrosine phosphatase inhibitor
0,335  0,030  5 Hydroxytryptamine uptake stimulant
0,313  0,012  Glutathione S-transferase substrate
0,303  0,004  Creatine kinase inhibitor
0,347  0,051  CYP2C19 substrate
0,339  0,045  Cytotoxic
0,324  0,033  Peroxidase inhibitor
0,315  0,023  UGT2B7 substrate
0,291  0,008  Xanthine oxidase inhibitor
0,360  0,081  GABA C receptor rho-3 antagonist
0,318  0,039  Antimitotic
0,324  0,047  Antiprotozoal (Leishmania)
0,334  0,059  Antineoplastic (melanoma)
0,292  0,020  Neurotrophic factor enhancer
0,336  0,065  Hepatic disorders treatment
0,293  0,023  Antineoplastic (squamous cell carcinoma)
0,287  0,019  Insulin sensitizer
0,322  0,054  Antineoplastic (small cell lung cancer)
0,275  0,009  UGT2B1 substrate
0,280  0,017  Nitric-oxide synthase stimulant
0,274  0,013  LDLR expression enhancer
0,259  0,004  Dopamine D5 antagonist
0,282  0,031  VCAM1 expression inhibitor
0,261  0,012  Endometrios treatment
0,299  0,056  Sensitization
0,307  0,065  Antineoplastic (osteosarcoma)
0,273  0,036  UGT1A4 substrate
0,240  0,005  Aldose reductase inhibitor
0,271  0,043  Antihypotensive
0,294  0,075  Antineoplastic (ovarian cancer)
0,233  0,018  Gout treatment
0,309  0,094  Antiprotozoal (Plasmodium)
0,224  0,014  SULT1A1 substrate
0,227  0,020  Alkylator
0,282  0,076  5 Hydroxytryptamine release stimulant
0,246  0,042  Pneumotoxic
0,238  0,037  Antiviral (Hepatitis)
0,227  0,028  UGT2B9 substrate
0,311  0,113  Antipruritic, allergic
0,266  0,069  Antipyretic
0,267  0,074  CYP1A2 inhibitor
0,259  0,074  Antineoplastic (non-small cell lung cancer)
0,217  0,033  Antiviral (Hepatitis C)
0,216  0,035  VEGF expression inhibitor
0,189  0,011  Prolactin inhibitor
0,299  0,125  Antiprotozoal
0,186  0,014  Multidrug resistance-associated protein 1 inhibitor
0,178  0,009  SULT1E1 substrate
0,203  0,034  NADPH oxidase inhibitor
0,177  0,010  Aromatase inhibitor
0,219  0,063  Antiviral (Influenza)
0,171  0,016  Histidine decarboxylase inhibitor
0,221  0,067  Antialcoholic
0,192  0,039  Tubulin antagonist
0,204  0,053  Prostatic (benign) hyperplasia treatment
0,170  0,023  Alpha 2 adrenoreceptor antagonist
0,234  0,088  Antineoplastic (renal cancer)
0,167  0,022  Antineoplastic (uterine cancer)
0,177  0,033  Cholesterol synthesis inhibitor
0,155  0,014  Dopamine D1 antagonist
0,167  0,027  Antineoplastic antibiotic
0,163  0,024  Papain-like protease (SARS coronavirus) inhibitor
0,266  0,129  Ulceration
0,226  0,092  Antineoplastic (sarcoma)
0,181  0,047  Carcinogenic, group 1
0,241  0,107  Antihypoxic
0,143  0,011  Lipase inhibitor
0,161  0,033  Antiadrenergic
0,158  0,033  Adrenaline antagonist
0,144  0,020  NAD(P)H dehydrogenase (quinone) inhibitor
0,151  0,028  Carbonic anhydrase III inhibitor
0,253  0,131  Vasodilator, coronary
0,155  0,033  Gastritis treatment
0,136  0,014  Antiprotozoal activity enhancer
0,125  0,003  Dopamine D5 agonist
0,151  0,033  Contraceptive female
0,145  0,027  Beta glucuronidase inhibitor
0,234  0,119  Metabolic disease treatment
0,176  0,061  UGT2B10 substrate
0,117  0,003  Dopamine D1 agonist
0,169  0,056  Protein kinase stimulant
0,255  0,145  CYP2C9 substrate
0,135  0,026  Alpha 2a adrenoreceptor antagonist
0,139  0,031  Protein kinase C mu inhibitor
0,208  0,100  Antineoplastic (liver cancer)
0,141  0,034  Carbonic anhydrase XV inhibitor
0,120  0,013  SULT1A2 substrate
0,151  0,048  DNA polymerase I inhibitor
0,107  0,005  Postcoital contraceptive
0,132  0,033  DOPA decarboxylase inhibitor
0,155  0,058  MAO inhibitor
0,173  0,076  Succinate dehydrogenase inhibitor
0,112  0,016  Adrenaline uptake inhibitor
0,244  0,148  Stroke treatment
0,210  0,115  Lipoprotein disorders treatment
0,182  0,086  Abortion inducer
0,118  0,024  Opioid kappa receptor antagonist
0,157  0,064  Antineoplastic (carcinoma)
0,123  0,032  UGT2B11 substrate
0,105  0,014  Alpha tubulin antagonist
0,168  0,078  Toxic, respiratory center
0,123  0,035  Opioid antagonist
0,205  0,117  Immunostimulant
0,127  0,039  Electron transport complex I inhibitor
0,112  0,024  Keratolytic
0,106  0,020  Narcotic antagonist
0,156  0,071  Interferon gamma antagonist
0,108  0,023  Antiviral (Hepatitis A)
0,129  0,048  MAO A inhibitor
0,174  0,093  CYP2B6 inhibitor
0,117  0,042  Anabolic
0,134  0,061  M18 aspartyl aminopeptidase inhibitor
0,137  0,065  Cyclooxygenase 1 inhibitor
0,111  0,039  Carcinogenic, group 2A
0,135  0,062  Cyclooxygenase 3 inhibitor
0,243  0,172  CYP2C9 inhibitor
0,110  0,039  Androgen antagonist
0,238  0,168  Antiobesity
0,087  0,017  SULT2A1 substrate
0,097  0,030  Histone deacetylase SIRT1 stimulant
0,097  0,030  Histone deacetylase stimulant
0,206  0,139  Antidepressant
0,187  0,120  RNA-directed DNA polymerase inhibitor
0,081  0,014  Dopamine D2 agonist
0,082  0,016  Transcription factor RelA inhibitor
0,123  0,057  Microtubule formation inhibitor
0,158  0,093  Carcinogenic
0,180  0,116  Antineoplastic (lymphocytic leukemia)
0,102  0,038  Carbonic anhydrase VI inhibitor
0,075  0,012  Progesterone antagonist
0,093  0,031  Ca(v)3.1 blocker
0,065  0,003  Toll-Like receptor 4 agonist
0,221  0,165  GST A substrate
0,145  0,092  Antihelmintic (Nematodes)
0,167  0,115  Dependence treatment
0,137  0,086  Ca2+-transporting ATPase inhibitor
0,149  0,099  Antipruritic, non-allergic
0,079  0,029  Glutamate (mGluR7) antagonist
0,067  0,018  Topoisomerase II beta inhibitor
0,054  0,005  Estrogen-related receptor beta antagonist
0,125  0,076  Antihelmintic (Trematoda)
0,133  0,085  Cyclooxygenase inhibitor
0,136  0,088  Adenylate cyclase stimulant
0,107  0,060  Alpha 2c adrenoreceptor antagonist
0,072  0,024  Fatty acid synthase inhibitor
0,074  0,028  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,058  0,012  Glucocorticoid antagonist
0,117  0,073  Antiviral (Influenza B)
0,062  0,019  Estradiol 17 beta-dehydrogenase inhibitor
0,134  0,093  Antidiarrheal
0,141  0,099  Arachidonic acid antagonist
0,086  0,045  Na+ K+ transporting ATPase inhibitor
0,064  0,023  Dopamine transporter inhibitor
0,155  0,116  Antirickettsial
0,123  0,085  Antifungal enhancer
0,049  0,017  Kinesin antagonist
0,049  0,017  Kinesin-like protein 1 inhibitor
0,119  0,087  Interleukin 4 antagonist
0,123  0,091  Psychosexual dysfunction treatment
0,093  0,061  Alpha adrenoreceptor antagonist
0,104  0,072  Mucolytic
0,059  0,030  Opioid agonist
0,087  0,059  Ornithine decarboxylase inhibitor
0,045  0,018  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,067  0,041  HIV-1 integrase (3'-Processing) inhibitor
0,054  0,028  Squalene epoxidase inhibitor
0,098  0,072  Toll-Like receptor 4 antagonist
0,156  0,131  Hypolipemic
0,049  0,025  Opioid kappa receptor agonist
0,090  0,066  MAO B inhibitor
0,077  0,055  Macrophage migration inhibitory factor inhibitor
0,043  0,021  Cholesterol absorption inhibitor
0,062  0,041  Neuraminidase inhibitor
0,059  0,040  Beta tubulin antagonist
0,171  0,152  Radioprotector
0,091  0,073  Dementia treatment
0,161  0,144  Tumour necrosis factor alpha release inhibitor
0,088  0,072  Vascular dementia treatment
0,057  0,041  Dopamine uptake inhibitor
0,056  0,041  Xanthine dehydrogenase inhibitor
0,126  0,113  GABA C receptor rho-2 antagonist
0,200  0,188  Sodium/bile acid cotransporter inhibitor
0,027  0,016  Sodium/glucose cotransporter 2 inhibitor
0,032  0,022  Nucleoside transporters inhibitor
0,026  0,017  Sodium/glucose cotransporter inhibitor
0,018  0,009  NMDA receptor phencyclidine site antagonist
0,079  0,070  D-Ala-D-Ala ligase inhibitor
0,085  0,076  Protein kinase C zeta inhibitor
0,082  0,076  Sodium/hydrogen exchanger 5 inhibitor
0,036  0,030  Glucose-6-phosphate dehydrogenase inhibitor
0,157  0,151  Cardiovascular analeptic
0,104  0,099  Cyclooxygenase 2 inhibitor
0,078  0,074  Estrogen-related receptor beta agonist
0,093  0,089  GABA C receptor antagonist
0,068  0,064  Analgesic, opioid
0,021  0,017  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,082  0,079  5-Lipoxygenase inhibitor
0,118  0,115  Antiviral (Herpes)
0,049  0,046  Protein kinase C eta inhibitor
0,138  0,136  Antineoplastic (bone cancer)
0,071  0,069  Antitreponemal
0,058  0,056  Opioid mu receptor antagonist
0,096  0,095  Beta amyloid protein antagonist
0,054  0,053  Glucagon-like peptide 1 agonist
0,019  0,018  Estrone sulfatase inhibitor
0,081  0,081  Uric acid excretion stimulant

